mcherry or meos nanobodies and their preparation methods and applications
A nanobody and expression carrier technology, applied in the field of bioengineering, can solve problems such as poor batch stability, poor acid-base stability, and variability, and achieve the effects of low cost, good stability, and strong affinity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0052] The preparation method of mcherry nanobody includes the following steps:
[0053] (1) Construction of mcherry nanobody library:
[0054] (1.1) The protein used for immunization is the mcherry protein expressed by Escherichia coli. For the first immunization, 1 mg of antigenic protein (including 0.25 mg of mcherry protein) was mixed with an equal volume of Freund's complete adjuvant and emulsified. Partial point injection, a total of four immunizations, once every two weeks, each immunization protein dosage is 0.5mg (including 0.125mg mcherry protein), and the adjuvant used for booster immunization is incomplete Freund's adjuvant. About four days after the fourth vaccination, at least 20 mL of alpaca whole blood was collected, and PBMCs were isolated using lymphocyte separation medium.
[0055] (1.2) Extract the total RNA of PBMC (using trizol method).
[0056] (1.3) Reverse transcription of RNA into cDNA. The operation steps are carried out according to the instructio...
Embodiment 2
[0093] The preparation method of mEOS nanobody includes the following steps:
[0094] (1) Construction of mEOS nanobody library:
[0095] (1.1) The protein used for immunization is the mEOS protein expressed by Escherichia coli. For the first immunization, 0.5 mg of mEOS protein was mixed with an equal volume of Freund's complete adjuvant and emulsified. Four times, once every two weeks, the dose of protein for each immunization was 0.5 mg, and the adjuvant used for boosting immunization was incomplete Freund's adjuvant. About four days after the fourth vaccination, at least 20 mL of alpaca whole blood was collected, and PBMCs were isolated using lymphocyte separation medium.
[0096] (1.2) Extract the total RNA of PBMC (using trizol method).
[0097] (1.3) Reverse transcription of RNA into cDNA. The operation steps are carried out according to the instructions of PrimeScript™ II 1st Strand cDNASynthesis Kit (purchased from takara).
[0098] (1.4) Amplify the VHH fragment b...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


